Description
Trade name:
Erectalis
Compound:
Each tablet contains:
Tadalafil 20 mg
Auxiliary components:
Microcrystalline cellulose, lactose monohydrate, sodium croscarmellose, hydroxypropyl methylcellulose, sodium lauryl sulfate, magnesium stearate, dye.
Properties:
Tadalafil is a reversible, selective inhibitor of specific phosphodiesterase type 5.
Indications:
Erectile dysfunction.
Method of administration and dosage:
For patients with sexual activity less than 2 times a week, it is recommended to prescribe Erectalis at a dose of 20 mg, immediately before sexual activity, according to the instructions for medical use of the drug.
The maximum daily dose of Erectalis is 20 mg.
Contraindications:
Use of preparations containing any organic nitrates;
The presence of contraindications to sexual activity in patients with cardiovascular diseases: myocardial infarction within the last 90 days, unstable angina, occurrence of an attack of angina during sexual intercourse, chronic heart failure class II and higher according to the NYHA classification within the last 6 months, uncontrolled arrhythmias, arterial hypotension (BP less than 90/50 mm Hg), uncontrolled arterial hypertension, ischemic stroke within the last 6 months;
Loss of vision due to non-arteritic anterior ischemic optic neuropathy (regardless of association with PDE5 inhibitors);
Concomitant use with doxazosin, other PDE5 inhibitors, other erectile dysfunction therapies, guanylate cyclase stimulators such as riociguat;
Chronic renal failure (CC less than 30 ml/min);
Age up to 18 years;
Lactase deficiency, lactose intolerance, glucose-galactose malabsorption;
Hypersensitivity to tadalafil or to any of the excipients contained in the drug.
Precautions:
Since there are insufficient data in patients with severe hepatic impairment (Child-Pugh class C), caution should be exercised when prescribing Erectalis to this group of patients.
Caution should be exercised when prescribing Erectalis to patients taking alpha1-adrenergic blockers, as concomitant use of these drugs may result in symptomatic hypotension in some patients.
When a single dose of tadalafil is administered, no symptomatic hypotension is observed when co-administered with tamsulosin, a selective alpha1-adrenergic blocker.
Erectilis should be used with caution in patients with a predisposition to priapism (sickle cell anemia, multiple myeloma or leukemia) or in patients with anatomical deformation of the penis (angular curvature, cavernous fibrosis or Peyronie’s disease).
Caution should also be exercised when taken concomitantly with CYP3A4 isoenzyme inhibitors (ritonavir, saquinavir, ketoconazole, itraconazole, clarithromycin, erythromycin, grapefruit juice), antihypertensive agents, 5-alpha-reductase inhibitors.
Side effects:
The most common adverse events in patients with erectile dysfunction are headache and dyspepsia, as well as back pain, myalgia,
hypersensitivity reactions, headache, dizziness, blurred vision, tinnitus, palpitations, tachycardia,
“flushes” of blood to the face, nasal congestion, dyspepsia, diarrhea in patients over 65 years of age, vomiting, nausea, myalgia, pain in the extremities.
Storage method:
At a temperature not exceeding 30 degrees.
